BeStock  

基立福 GRFS

美股市值排名 #1951药品制造-综合
$8.43 −$0.03 (-0.35%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $8.43 0.00%
开盘$8.30
昨收$8.46
当日区间$8.26 – $8.55
成交量610.3K
市值$5.74B
市盈率(TTM)10.5
股息率1.25%

基本面

最新报告季度:Q2, ended Jun 2026 · 报告货币为EUR

营收€1.87B-0.9% YoY
营业利润€329.00M-6.0% YoY
净利润€183.00M+32.6% YoY
摊薄每股收益€0.23+32.3% YoY
自由现金流€108.00M+71.4% YoY
经营现金流€227.00M

营收,近8个季度

€1.8BSep '24€2.0BDec '24€1.8BMar '25€1.9BJun '25€1.9BSep '25€2.0BDec '25€1.7BMar '26€1.9BJun '26

净利润,近8个季度

€82.0MSep '24€84.0MDec '24€92.0MMar '25€138.0MJun '25€143.4MSep '25€125.8MDec '25€88.0MMar '26€183.0MJun '26

各季度摊薄每股收益

0.08Sep '240.10Dec '240.09Mar '250.17Jun '250.19Sep '250.14Dec '250.11Mar '260.23Jun '26

各季度自由现金流

€215.4MSep '24€371.1MDec '24€48.0MMar '25€63.0MJun '25€218.8MSep '25€296.7MDec '25€20.0MMar '26€108.0MJun '26

年度营收

€5.3BFY20€4.9BFY21€6.1BFY22€6.6BFY23€7.2BFY24€7.5BFY25

盈利能力与资产负债表

毛利率37.0%
营业利润率16.2%
净利率6.1%
净资产收益率8.4%
资产收益率2.3%
投入资本回报率5.9%
流动比率2.37
负债/资产比率60.3%
现金及投资€529.00M
总负债€8.40B
净现金(净负债)-€7.87B
自由现金流/营收8.6%

营收构成

2025/FY 季度

按业务线

  • BioPharma€6.49B 86.2%
  • Diagnostic€640.00M 8.5%
  • Others€243.00M 3.2%
  • Bio Supplies€154.00M 2.0%

按地区

  • USA and Canada€4.25B 56.5%
  • Rest of the World€1.66B 22.0%
  • Rest of European Union€1.20B 15.9%
  • Spain€418.00M 5.6%

该公司以本国货币报告财务数据,并非美元。以下数字均标注了实际货币单位,未自动换算。

利润表

项目 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
报告营业总收入 €1.87B €1.70B €7.52B €1.98B €1.87B
营业总收入 €1.87B €1.70B €7.52B €1.98B €1.87B
营业成本 €1.17B €1.08B €4.67B €1.29B €1.13B
毛利润 €705.00M €620.00M €2.86B €686.84M €733.70M
营业费用 €376.00M €371.00M €1.61B €411.46M €381.58M
销售及管理费用 €289.00M €281.00M €1.06B €155.30M €284.99M
研发费用 €87.00M €90.00M €426.00M €136.74M €97.02M
营业利润 €329.00M €249.00M €1.25B €275.38M €352.11M
非经营性利息净收入(支出) -€79.00M -€139.00M -€605.00M -€136.99M -€156.07M
其他财务成本合计 €79.00M €139.00M €63.00M – –
其他收入(支出) -€3.00M €2.00M -€31.00M -€27.29M €2.09M
权益法投资收益 -€3.00M €2.00M -€8.00M -€4.29M €2.09M
税前利润 €247.00M €112.00M €615.00M €111.10M €198.13M
税费 €64.00M €24.00M €115.00M -€14.68M €54.71M
净利润 €183.00M €88.00M €500.00M €125.77M €143.43M
持续经营利润 €183.00M €88.00M €500.00M €125.77M €143.43M
少数股东权益 €29.00M €15.00M €98.00M €27.52M €16.46M
归属母公司净利润 €155.00M €73.00M €402.00M €98.25M €126.97M
归属普通股股东净利润 €155.00M €73.00M €402.00M €98.25M €126.97M
基本每股收益 €0.23 €0.11 €0.59 €0.14 €0.19
摊薄每股收益 €0.23 €0.11 €0.59 €0.14 €0.19
每股股息 €0.09 €0.00 €0.15 €0.00 €0.15
-管理费用 – – €1.06B – –
折旧、摊销与折耗 – – €120.00M – –
-折旧与摊销 – – €120.00M – –
其他营业费用 – – -€1.00M -€570,000.00 -€430,000.00
非经营性利息收入 – – €34.00M – –
非经营性利息支出 – – €576.00M €107.99M €156.07M
证券出售收益 – – -€20.00M – –
特殊收益(费用) – – -€3.00M – –
-减:核销 – – €3.00M – –

资产负债表

项目 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
总资产 €20.09B €20.08B €19.71B €19.71B €19.85B
流动资产合计 €5.31B €5.25B €5.07B €5.07B €5.35B
现金及现金等价物与短期投资 €529.00M €758.00M €824.00M €824.00M €825.48M
-现金及现金等价物 €513.00M €702.00M €801.00M €801.00M €620.96M
-短期投资 €16.00M €56.00M €23.00M €23.00M €204.52M
应收款 €1.19B €958.00M €856.00M €856.00M €1.10B
-应收账款 €686.00M €863.00M €651.00M €651.00M €1.00B
-应收贷款 €167.00M – €12.00M €12.00M –
-应收税款 €64.00M – €72.00M €72.00M –
-其他应收款 €272.00M €95.00M €121.00M €121.00M €95.74M
预付资产 €17.00M – €9.00M €9.00M –
存货 €3.49B €3.46B €3.30B €3.30B €3.35B
受限现金 €0.00 – €24.00M €24.00M –
其他流动资产 €76.00M €78.00M €65.00M €65.00M €78.39M
非流动资产合计 €14.79B €14.82B €14.64B €14.64B €14.50B
固定资产净值 €4.06B €3.16B €4.05B €4.05B €3.11B
-固定资产原值 €6.92B – €6.72B €6.72B €3.11B
-累计折旧 -€2.86B – -€2.66B -€2.66B –
投资及预付款 €402.00M €609.00M €460.00M €460.00M €496.70M
-可供出售证券 €281.00M €500.00M €361.00M €361.00M –
-长期股权投资 €117.00M €109.00M €97.00M €97.00M €82.24M
金融资产 €0.00 – €0.00 €0.00 –
一年以上应收票据 €12.00M – €133.00M €133.00M –
一年以上预付资产 €18.00M – €16.00M €16.00M –
商誉及其他无形资产 €9.82B €10.62B €9.56B €9.56B €10.51B
-商誉 €7.02B – €6.83B €6.83B –
-其他无形资产 €2.80B – €2.73B €2.73B –
一年以上递延资产 €476.00M – €416.00M €416.00M –
负债合计 €12.11B €12.23B €12.11B €12.11B €12.31B
流动负债合计 €2.24B €2.12B €2.02B €2.02B €2.15B
应付款 €1.36B – €1.35B €1.35B –
-应付账款 €1.00B – €841.00M €841.00M –
-应付税款合计 €92.00M – €50.00M €50.00M –
-其他应付款 €268.00M – €456.00M €456.00M –
短期债务及融资租赁负债 €420.00M €589.00M €523.00M €523.00M –
-一年内到期债务 €303.00M – €410.00M €410.00M –
-一年内到期融资租赁负债 €117.00M – €113.00M €113.00M –
一年内预提费用 €33.00M – €35.00M €35.00M –
其他流动负债 €422.00M €1.54B €80.00M €80.00M €2.15B
非流动负债合计 €9.87B €10.11B €10.09B €10.09B €10.15B
长期债务及融资租赁负债 €8.10B €9.08B €9.04B €9.04B –
-长期债务 €7.17B – €8.07B €8.07B –
-长期融资租赁负债 €928.00M – €969.00M €969.00M –
衍生产品负债 €2.00M – €1.00M €1.00M –
非流动负债 €121.00M – €119.00M €119.00M –
一年以上递延负债 €942.00M – €877.00M €877.00M –
其他非流动负债 €712.00M €1.03B €50.00M €50.00M €10.15B
股东权益合计 €7.98B €7.85B €7.60B €7.60B €7.55B
股东权益 €5.55B €5.46B €5.27B €5.27B €5.18B
股本 €120.00M €120.00M €120.00M €120.00M €119.60M
-普通股 €120.00M €120.00M €120.00M €120.00M €119.60M
资本公积 €911.00M €911.00M €911.00M €911.00M €910.73M
留存收益 €227.00M €73.00M €300.00M €300.00M €303.75M
减:库存股 €131.00M €131.00M €131.00M €131.00M €130.67M
不影响留存收益的损益 €4.42B €4.49B €4.07B €4.07B €3.98B
少数股东权益 €2.43B €2.39B €2.33B €2.33B €2.37B
其他非流动资产 – €428.00M – – €385.35M
一年内递延负债 – – €34.00M €34.00M –

现金流量表

项目 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
经营活动现金流 €227.00M €110.00M €1.05B €430.86M €325.40M
持续经营经营活动现金流净额 €227.00M €110.00M €1.05B €430.86M €325.40M
持续经营净利润 €286.00M €73.00M €615.00M €311.25M €126.96M
折旧、折耗与摊销 €107.00M €104.00M €450.00M €128.37M €102.85M
其他非现金项目 €199.00M €19.00M €645.00M €474.43M €145.01M
营运资金变动 -€100.00M -€107.00M -€31.00M €164.75M -€37.50M
-应收款变动 -€50.00M -€21.00M -€32.00M €99.49M -€13.34M
-存货变动 -€50.00M -€134.00M -€97.00M €20.69M -€26.26M
-应付账款及应计费用变动 €3.00M €48.00M €94.00M €40.58M €2.09M
投资活动现金流净额 -€128.00M -€118.00M -€579.00M -€151.32M -€122.68M
持续经营投资活动现金流净额 -€128.00M -€118.00M -€579.00M -€151.32M -€122.68M
无形资产购置及出售净额 -€53.00M -€38.00M -€158.00M -€48.60M -€36.53M
业务购买及出售净额 €0.00 -€19.00M -€108.00M -€5.83M €5,000.00
筹资活动现金流 -€295.00M -€130.00M -€529.00M -€75.18M -€138.76M
持续经营筹资活动现金流净额 -€300.00M -€125.00M -€529.00M -€75.18M -€138.77M
债务发行及偿还净额 €57.00M -€117.00M -€119.00M €146.60M -€41.85M
其他筹资费用净额 -€352.00M -€13.00M -€282.00M -€192.69M €5.47M
期末现金余额 €513.00M €702.00M €825.00M €825.00M €620.96M
现金净变动 -€196.00M -€138.00M -€61.00M €204.37M €63.95M
期初现金余额 €702.00M €825.00M €980.00M €620.96M €558.69M
汇率变动影响 €7.00M €15.00M -€94.00M -€547,000.00 -€1.68M
自由现金流 €108.00M €20.00M €624.00M €296.72M €218.82M
资本支出 – -€52.00M – – -€70.05M
其他投资变动净额 – -€9.00M – – -€16.11M
持续经营损益 – – €10.00M – –
-其他流动资产变动 – – €4.00M – –
固定资产购置及出售净额 – – -€261.00M – –
投资购置及出售净额 – – -€52.00M – –
已付现金股利 – – -€128.00M -€25.62M -€102.38M
普通股发行净额 – – – – €0.00

讨论区

暂无评论——快来第一个聊聊 GRFS。

登录后参与讨论。

Scroll to Top